ApiRays® is a group of passionate researchers, academicians, business developers and legal attorneys that strive to develop efficient biotechnical solutions for cost-effective diagnostics. We are located in the renowned Karolinska Instititutet campus in the middle of the inspiring environment of the new life-sciences-hub Hagastaden, located in beautiful Stockholm.
We have developed a recombinant apyrase enzyme called ApiOne® from bacterial origin that can instantly eliminate ATP and ATP by-products. Using ApiOne® in ATP-based diagnostics, it is possible to improve the sensitivity of methods, including bioluminescence and colorimetric tests. This activity helps ATP-based diagnostics to extend its applications in biomedicine, food and beverages, drug discovery and pharmaceutical industries.
ApiOne® provides significant advantages for the DNA sequencing industry, especially Pyrosequencing as it can increase the DNA read-lengths by at least 20%. Our patented solutions not only provide a superior alternative to potato apyrase but also reduce the experimental turn-around time up to 40%, thus cost.
We are very happy and proud to announce a collaboration with our partners for a clinical evaluation of our products! Our hope is to develop a standardized pipeline for bacterial blood and urine analyses.
We are happy to announce that we have reached an extended production agreement with our supplier in the EU, ensuring delivery of our high quality products at beneficial prices.